One- versus 2-day aspirin desensitization in aspirin exacerbated respiratory disease: A quality improvement project

One- versus 2-day aspirin desensitization in aspirin exacerbated respiratory disease: A quality improvement project

Background: Current aspirin desensitization protocols for aspirin-exacerbated respiratory disease (AERD) require from 1 to 3 days to complete. Objective: Our aim was to assess the implementation of a 1-day versus 2-day aspirin desensitization protocol in patients with aspirin-exacerbated respiratory...

Full description

Bibliographic Details
Main Authors:	Emily Gansert, BS, Dan Morgenstern-Kaplan, MD, MS, Angela M. Donaldson, MD, Matthew A. Rank, MD, Alexei Gonzalez-Estrada, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Journal of Allergy and Clinical Immunology: Global
Subjects:	Aspirin-exacerbated respiratory disease aspirin desensitization quality improvement nonsteroidal anti-inflammatory drugs
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772829323000838

Similar Items

A Review of Aspirin-exacerbated Respiratory Diseases and Immunological Efficacy of Aspirin Desensitization
by: Hossein Esmaeilzadeh, et al.
Published: (2022-10-01)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
by: Dorien Van Broeck, et al.
Published: (2023-04-01)

Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease
by: Lucyna Mastalerz, et al.
Published: (2021-08-01)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)
by: Jonas Willian Spies, et al.

Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
by: Lindsey Ryan, et al.
Published: (2020-12-01)

Aspirin-Exacerbated Asthma
by: Varghese Mathew, et al.
Published: (2008-06-01)

The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
by: Tran Locke, et al.
Published: (2020-12-01)

Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
by: Kevin L. Li, et al.
Published: (2019-03-01)

Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women
by: Filipe Benito-Garcia, et al.
Published: (2021-04-01)

Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions
by: Elina Jerschow, MD, MSc, et al.
Published: (2024-05-01)

Aspirin-exacerbated respiratory disease: Update on medical management
by: Andrew A. White, et al.
Published: (2020-12-01)

Aspirin desensitization in nonsteroidal anti-inflammatory exacerbated respiratory disease: The first prospective cohort in Chile
by: María Josefina Siña, et al.
Published: (2023-02-01)

The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
by: Kathleen Buchheit, et al.
Published: (2020-12-01)

Association Analysis of Polymorphisms with Aspirin-Exacerbated Respiratory Disease in a Korean Population
by: Jin Sol Lee, et al.
Published: (2014-06-01)

Clinical pictures of phenotypes of intolerance to aspirin and other nonsteroidal anti-inflammatory drugs. Part I
by: Iwona Grzelewska-Rzymowska, et al.
Published: (2014-12-01)

Local and Systemic Production of Pro-Inflammatory Eicosanoids Is Inversely Related to Sensitization to Aeroallergens in Patients with Aspirin-Exacerbated Respiratory Disease
by: Daniel P. Potaczek, et al.
Published: (2022-03-01)

Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
by: Steinke JW, et al.
Published: (2016-03-01)

Endoscopic sinus surgery and aspirin desensitization improve otologic-specific SNOT-22 scores
by: James G. Naples, et al.
Published: (2020-12-01)

A single center experience of rapid aspirin desensitization in acute coronary syndrome patients
by: Christoforos Vlachos, et al.
Published: (2022-03-01)

Aspirin: yesterday, today, and tomorrow
by: Marina Nikołajewna Dołżenko
Published: (2014-06-01)

Aspirin : the miracle drug /
by: 296334 Metcalf, Eric
Published: (2005)

Endogenous cannabinoids may regulate chronic inflammation in aspirin-exacerbated respiratory disease
by: Joshua M. Levy
Published: (2020-12-01)

Comparative antinociceptive effect of aspirin and aspirin nano particles in semisolid formulae in mice
by: Labeeb H. Al- Alsadoon, et al.
Published: (2021-04-01)

Aspirin tablets
by: 982 SIRIM

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
by: Daniel B. Spielman, et al.
Published: (2020-12-01)

Appropriate extent of surgery for aspirin-exacerbated respiratory disease
by: Ethan G. Muhonen, et al.
Published: (2020-12-01)

Association of eosinophil‐derived neurotoxin levels with asthma control status in patients with aspirin‐exacerbated respiratory disease
by: Ga‐Young Ban, et al.
Published: (2023-03-01)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
by: Nischal N Hegde, et al.
Published: (2023-01-01)

Aural polyps in aspirin-exacerbated respiratory disease
by: Amy E. Schettino, et al.
Published: (2020-11-01)

Comparison of Two Therapeutic Protocols : Heparin with Aspirin VS Prednisolone with Aspirin, in Patients with Recurrent Miscarriages
by: S. Rabiee, M.D., et al.
Published: (2007-01-01)

The Role of Mast Cells in Aspirin-Exacerbated Respiratory Disease (AERD) Pathogenesis: Implications for Future Therapeutics
by: Kuruvilla ME, et al.
Published: (2020-10-01)

ASA Allergy and Desensitization Protocols in the Management of CAD: A Review of Literature
by: Monica Verdoia, et al.
Published: (2023-08-01)

Aspirin in dermatology: Revisited
by: Aditya Kumar Bubna
Published: (2015-01-01)

Risk of Peptic Ulcer Bleeding Associated with Infection, Nonsteroidal Anti-inflammatory Drugs, and Low-dose Aspirin Therapy in Peptic Ulcer Disease: A Case-control Study
by: Seung In Seo, et al.
Published: (2019-03-01)

NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates
by: Yoshihiro Suzuki, et al.
Published: (2010-05-01)

Synthesis and utilization of β-cyclodextrin modified chitosan for the adsorption of aspirin /
by: Muhammad Asyiq Azman, 1994-, author 625446, et al.
Published: (2019)

Synthesis and utilization of β-cyclodextrin modified chitosan for the adsorption of aspirin /
by: Muhammad Asyiq Azman, 1994-, author 625446
Published: (2019)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
by: Mojtaba Khazaei, et al.
Published: (2019-03-01)

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
by: Esha Sehanobish, et al.
Published: (2021-06-01)

The prevalence and associated factors of aspirin resistance among prophylactic aspirin users
by: Samaneh Ghorbani-Shirkouhi, et al.
Published: (2021-03-01)